SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001659617-19-000125
Filing Date
2019-08-13
Accepted
2019-08-13 07:34:16
Documents
4
Period of Report
2019-08-13
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-kq32019lymphonatrial.htm 8-K 21104
2 EXHIBIT 99.1 exh991-pressreleaselymphom.htm EX-99.1 10782
3 moleculin-logo_horiza05.jpg GRAPHIC 132868
4 moleculinlogoa18.jpg GRAPHIC 11658
  Complete submission text file 0001659617-19-000125.txt   221633
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

IRS No.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37758 | Film No.: 191018248
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1